| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/23/2012 | EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 05/23/2012 | EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol |
| 05/23/2012 | CN1906162B Hydroxy piperidine derivatives to treat gaucher disease |
| 05/23/2012 | CN1720066B Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 05/23/2012 | CN1659288B Pharmaceutical composition for preventing or reducing DNA damage |
| 05/23/2012 | CN102471769A 用于具有美容功能的细胞的遗传修饰以提高美容外观的方法和组合物 For having a cosmetic function of the genetic modification of cells in order to improve the cosmetic appearance of the methods and compositions |
| 05/23/2012 | CN102465125A 一种靶向golph3基因干扰小分子rna及其抗胶质瘤迁移的用途 One kind of gene targeting golph3 rna interference and small molecule anti-glioma migration purposes |
| 05/23/2012 | CN102464705A 白念珠菌致病相关基因sfl2及其用途 Candida albicans virulence-related genes and their use sfl2 |
| 05/23/2012 | CN102462846A 一种氯代毒素修饰的脑胶质瘤靶向基因递释复合物及其制备方法 One kind of toxin-modified chlorinated glioma targeted gene delivery release compound and preparation method |
| 05/23/2012 | CN102071205B Specific antigen of clonorchis sinensis and application thereof |
| 05/23/2012 | CN101892239B Schistosoma japonicum katsurada Frizzled 9 gene, protein and use |
| 05/23/2012 | CN101798600B Application of SERPINE2 gene |
| 05/23/2012 | CN101787358B Tet-Off Advanced human stably expressing high-transition nasopharyngeal carcinoma cell line S18, construction method thereof and application thereof |
| 05/23/2012 | CN101724653B Medicament containing natriuretic peptide gene as well as preparation method and application thereof |
| 05/23/2012 | CN101665800B Method for preparing micro-ecological preparation and application thereof |
| 05/23/2012 | CN101624581B Pseudovirus based on Vasohibin gene and preparation method and application thereof |
| 05/23/2012 | CN101580540B Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof |
| 05/23/2012 | CN101411326B Use of ShRNA in preparing medicament for improving survival ratio of xenogenic organ transplantation |
| 05/23/2012 | CN101374853B Methods and compositions for cancer therapy using a novel adenovirus |
| 05/23/2012 | CN101353668B Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof |
| 05/22/2012 | US8183363 Antisense oligonucleotide modulation of STAT3 expression |
| 05/22/2012 | US8183362 Method and medicament for inhibiting the expression of a given gene |
| 05/22/2012 | US8183361 Oligonucleotide-containing pharmacological compositions and their use |
| 05/22/2012 | US8183223 Method for detecting carcinoma and agent for suppressing carcinoma |
| 05/22/2012 | US8183222 Method to inhibit cell growth using oligonucleotides |
| 05/22/2012 | US8183221 Suppression of SCN9A gene expression and/or function for the treatment of pain |
| 05/22/2012 | US8183220 Double-effective vaccine vector against foot-and-mouth disease virus (FMDV), methods of preparing and using the same |
| 05/22/2012 | US8183219 Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof |
| 05/22/2012 | US8183218 Agent for inducing apoptosis comprising MSX1 or a gene encoding the same as an active ingredient |
| 05/22/2012 | US8183026 Methods of preparation of live attenuated bacterial vaccine by alteration of DNA adenine methylase (Dam) activity in those bacteria |
| 05/22/2012 | US8182996 Compositions and methods for detecting Klebsiella pneumoniae |
| 05/22/2012 | US8182804 Engineered enzymatically active bacteriophages and methods of uses thereof |
| 05/22/2012 | US8182802 Cationic block polymers containing 2-methacyloyloxyethyl-2,1-trimethyl ammonium ethyl phosphate liner salt with DNA; drug delivery |
| 05/22/2012 | CA2660355C Polynucleotide vaccine formulation against pathologies of the horse |
| 05/22/2012 | CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 05/22/2012 | CA2456169C Methods and compositions relating to improved lentiviral vector production systems |
| 05/22/2012 | CA2449013C Viral mutants that selectively replicate in targeted human cancer cells |
| 05/22/2012 | CA2386865C Diagnosis and therapy of cancer using sgp28-related molecules |
| 05/22/2012 | CA2348956C Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/22/2012 | CA2304254C Trimerising module |
| 05/18/2012 | WO2012065164A2 Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| 05/18/2012 | WO2012065059A2 Treatment of atherosclerosis with bmp-alk3 antagonists |
| 05/18/2012 | WO2012065027A2 Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases |
| 05/18/2012 | WO2012064967A2 Cancer cell-derived receptor activator of the nf-kb ligand drives bone and soft tissue metastases |
| 05/18/2012 | WO2012064930A1 Compositions and methods useful for treatment and prevention of incontinence |
| 05/18/2012 | WO2012064920A1 Methods, compositions, cells, and kits for treating ischemic injury |
| 05/18/2012 | WO2012064834A2 Methods for organ regeneration |
| 05/18/2012 | WO2012064758A2 Methods for modulating factor 12 expression |
| 05/18/2012 | WO2012064743A2 Methods for improving heart function |
| 05/18/2012 | WO2012064286A1 Targeting metabolic enzymes in human cancer |
| 05/18/2012 | WO2012063894A1 Compositions containing antisense oligonucleotide to micro rna |
| 05/18/2012 | WO2012027611A3 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
| 05/18/2012 | WO2012027017A3 Novel agonists of toll-like receptor 3 and methods of their use |
| 05/18/2012 | WO2012018866A3 Methods and compositions for the diagnosis and treatment of breast cancer |
| 05/18/2012 | CA2817709A1 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| 05/18/2012 | CA2816593A1 Methods for organ regeneration |
| 05/17/2012 | US20120123186 Therapeutic regimen for treating cancer |
| 05/17/2012 | US20120122963 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 05/17/2012 | US20120122217 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 05/17/2012 | US20120122216 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 05/17/2012 | US20120122204 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 05/17/2012 | US20120122111 Rna sequence-specific mediators of rna interference |
| 05/17/2012 | US20120122109 Neural progenitor cells derived from embryonic stem cells |
| 05/17/2012 | US20120121690 Method to enhance an immune response of nucleic acid vaccination |
| 05/17/2012 | US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/17/2012 | US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease |
| 05/17/2012 | US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin |
| 05/17/2012 | US20120121559 Treatment and prevention of pathological conditions using iduna related techniques and compositions |
| 05/16/2012 | EP2453024A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 05/16/2012 | EP2453019A1 Gene therapy compositions for preventing and/or treating autoimmune diseases |
| 05/16/2012 | EP2453016A1 Methods for treating hypercholesterolemia |
| 05/16/2012 | EP2453010A1 Neural progenitor cells derived from embryonic stem cells |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452189A1 Process for the identification of compounds for treating cancer |
| 05/16/2012 | EP2451953A2 Bioengineered silk protein-based nucleic acid delivery systems |
| 05/16/2012 | EP2451440A1 Amphoteric liposomes comprising imino lipids |
| 05/16/2012 | CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN |
| 05/16/2012 | CN102459616A Producer cells for replication competent retroviral vectors |
| 05/16/2012 | CN102459602A Neuron generation, regeneration and protection |
| 05/16/2012 | CN102459597A Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
| 05/16/2012 | CN102459596A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 05/16/2012 | CN102459576A Compositions and methods for modulating stem cells and uses thereof |
| 05/16/2012 | CN102459302A Nucleic acid delivery compositions and methods of use thereof |
| 05/16/2012 | CN102458480A Modulation of inflammatory responses by factor xi |
| 05/16/2012 | CN102458416A Interlaced method for treating cancer or a precancerous condition |
| 05/16/2012 | CN102458400A Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| 05/16/2012 | CN102453757A Application of micro RNA and antisense nucleic acid thereof in diagnosis, prevention, treatment and/or prognosis evaluation of myocardial ischemic injury |
| 05/16/2012 | CN102453722A Optimization of HIV (Human Immunodeficiency Virus)-gag gene inheritance codon and preparation method and application of AIDS (Acquired Immune Deficiency Syndrome) vaccine |
| 05/16/2012 | CN102453715A Small molecular interfering RNA for glioma angiogenesis resistance with high efficiency, preparation method and application thereof |
| 05/16/2012 | CN102453714A Small interference RNA used for inhibiting glioma migration |
| 05/16/2012 | CN102453713A HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer |
| 05/16/2012 | CN102453712A PI4KB siRNA and application thereof to preparation of medicament for inhibiting SARS-CoV infection |
| 05/16/2012 | CN102453095A Fusion protein containing GLP (glucagon-like peptide)-1 and preparation method and application thereof |
| 05/16/2012 | CN102453094A Fusion protein containing Exendin-4 and preparation method and application thereof |
| 05/16/2012 | CN102453066A Compound molecule, and preparation method and pharmaceutical composition thereof |
| 05/16/2012 | CN102451474A Antitumor effect, implementation method and usage of miRNA (micro-ribonucleic acid) |
| 05/16/2012 | CN102451473A MiRNA anti-tumor function, implementation method and application thereof |
| 05/16/2012 | CN102451472A Application of minimal heterodimer partner in blood lipid regulation |